Aerosols

Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update

Retrieved on: 
Thursday, October 22, 2020

Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs.

Key Points: 
  • Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs.
  • If successfully developed and approved, Verona Pharmas product candidate, ensifentrine, has the potential to be the first therapy for the treatment of respiratory diseases that combines bronchodilator and anti-inflammatory activities in one compound.
  • The Company is evaluating nebulized ensifentrine in its Phase 3 clinical program ENHANCE (Ensifentrine as a Novel inHAled Nebulized COPD thErapy) for COPD maintenance treatment.
  • Ensifentrine is in a pilot clinical study in patients hospitalized with COVID-19 and has potential applications in cystic fibrosis, asthma and other respiratory diseases.

InventHelp Inventors Develop Effective Tool for Collecting Dust (POO-555)

Retrieved on: 
Wednesday, October 21, 2020

The invention provides an effective way to collect and clean dust and particles.

Key Points: 
  • The invention provides an effective way to collect and clean dust and particles.
  • In doing so, it offers an improved alternative to traditional contractor push brooms.
  • As a result, it eliminates the need to inhale fine particulates and it enhances safety and efficiency.
  • The invention features a versatile and functional design that is convenient and easy to use so it is ideal for contractors, carpenters, do-it-yourselfers, etc.

Global Organic Deodorant Market | Rise in the Awareness About the Harmful Effects of Synthetic Deodorants to Boost Market Growth | Technavio

Retrieved on: 
Monday, October 19, 2020
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20201018005014/en/
    Technavio has announced its latest market research report titled Global Organic Deodorant Market 2020-2024 (Graphic: Business Wire)
    The global organic deodorant market is driven by various awareness campaigns undertaken by companies and industry associations for promoting the use of organic products.
  • Also, the global organic soap market is driven by the growing awareness among end-consumers about the harmful effects of traditional deodorants and benefits associated with organic deodorants.
  • Owing to the harmful effects of these chemicals, many people have started switching to organic deodorants, driving the expansion of the global market.
  • To help clients improve their market position, this organic deodorant market forecast report provides a detailed analysis of the market leaders.

Global Pneumatic Nebulizers Market to 2027: Amid the COVID-19 Pandemic, the Market is Projected to Reach a Revised $837.8 Million

Retrieved on: 
Friday, October 9, 2020

DUBLIN, Oct. 9, 2020 /PRNewswire/ -- The "Pneumatic Nebulizers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Oct. 9, 2020 /PRNewswire/ -- The "Pneumatic Nebulizers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Pneumatic Nebulizers estimated at US$649.5 Million in the year 2020, is projected to reach a revised size of US$837.8 Million by 2027, growing at a CAGR of 3.7% over the period 2020-2027.
  • Vented, one of the segments analyzed in the report, is projected to record 3.3% CAGR and reach US$337.1 Million by the end of the analysis period.
  • The U. S. Market is Estimated at $175.2 Million, While China is Forecast to Grow at 6.6% CAGR
    The Pneumatic Nebulizers market in the U. S. is estimated at US$175.2 Million in the year 2020.

Global Nebulizers Market Trajectory & Analytics Report 2020-2027: China will Remain Among the Fastest Growing Market

Retrieved on: 
Thursday, October 8, 2020

DUBLIN, Oct. 8, 2020 /PRNewswire/ -- The "Nebulizers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Oct. 8, 2020 /PRNewswire/ -- The "Nebulizers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • The U.S. Market is Estimated at $243.1 Million, While China is Forecast to Grow at 8% CAGR
    The Nebulizers market in the U.S. is estimated at US$243.1 Million in the year 2020.
  • In the global Ultrasonic Nebulizer segment, USA, Canada, Japan, China and Europe will drive the 5.3% CAGR estimated for this segment.
  • China will remain among the fastest growing in this cluster of regional markets.

Proveris Scientific Research Collaboration: New Generation Technologies for Improved Measurement of Pharmaceutical Aerosols

Retrieved on: 
Tuesday, October 6, 2020

Proveris Scientific Corporation , a leading provider of instrumentation and services to advance the science of aerosol and spray products, today announced its research collaboration with The University of Sydney and Macquarie University on a project to develop a new generation of technologies for improving the measurement of pharmaceutical aerosols.

Key Points: 
  • Proveris Scientific Corporation , a leading provider of instrumentation and services to advance the science of aerosol and spray products, today announced its research collaboration with The University of Sydney and Macquarie University on a project to develop a new generation of technologies for improving the measurement of pharmaceutical aerosols.
  • The project aims to develop an innovative optical tomography technology capable of direct and real-time measurement of the surface area of airborne particles.
  • The concept, originally conceived by Proveris Scientific, is to significantly enhance the characterization of inhaled aerosols with respect to their potential bioavailability or toxicity.
  • The multi-year research collaboration is funded by the Australian Research Council Linkage Program which promotes national and international research partnerships between researchers and business, industry, community organizations, and other publicly funded research agencies.

Global Pneumatic Nebulizers Market Trajectory & Analytics Report 2020 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 5, 2020

The "Pneumatic Nebulizers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pneumatic Nebulizers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Pneumatic Nebulizers estimated at US$649.5 Million in the year 2020, is projected to reach a revised size of US$837.8 Million by 2027, growing at a CAGR of 3.7% over the period 2020-2027.
  • The U. S. Market is Estimated at $175.2 Million, While China is Forecast to Grow at 6.6% CAGR
    The Pneumatic Nebulizers market in the U. S. is estimated at US$175.2 Million in the year 2020.
  • The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021.

Global Nebulizers Market Trajectory & Analytics Report 2020: Amid the COVID-19 Crisis, the Market is Projected to Reach a Revised $1.3 Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 5, 2020

The "Nebulizers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Nebulizers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Nebulizers estimated at US$896.6 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027.
  • Pneumatic Nebulizer, one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$887.6 Million by the end of the analysis period.
  • China, the world`s second largest economy, is forecast to reach a projected market size of US$265.5 Million by the year 2027 trailing a CAGR of 8% over the analysis period 2020 to 2027.

Nebulizer Market to Hit $1,698.1 Million Revenue by 2030: P&S Intelligence

Retrieved on: 
Monday, October 5, 2020

This factor would be instrumental in driving the global nebulizer market from $765.1 million in 2019 to $1,698.1 million in 2030 at a steady 7.4% CAGR between 2020 and 2030, according to P&S Intelligence.

Key Points: 
  • This factor would be instrumental in driving the global nebulizer market from $765.1 million in 2019 to $1,698.1 million in 2030 at a steady 7.4% CAGR between 2020 and 2030, according to P&S Intelligence.
  • This is driving the nebulizer market, as such appliances are used to aerosolize the medication and deliver it directly to the lungs.
  • In the years to come, the mesh category will witness the fastest advance in the nebulizer market, based on product type.
  • During the next decade, the Asia-Pacific (APAC) region is projected to advance the most rapidly in the nebulizer market.

Nebulizer Market to Hit $1,698.1 Million Revenue by 2030: P&S Intelligence

Retrieved on: 
Monday, October 5, 2020

This factor would be instrumental in driving the global nebulizer market from $765.1 million in 2019 to $1,698.1 million in 2030 at a steady 7.4% CAGR between 2020 and 2030, according to P&S Intelligence.

Key Points: 
  • This factor would be instrumental in driving the global nebulizer market from $765.1 million in 2019 to $1,698.1 million in 2030 at a steady 7.4% CAGR between 2020 and 2030, according to P&S Intelligence.
  • This is driving the nebulizer market, as such appliances are used to aerosolize the medication and deliver it directly to the lungs.
  • In the years to come, the mesh category will witness the fastest advance in the nebulizer market, based on product type.
  • During the next decade, the Asia-Pacific (APAC) region is projected to advance the most rapidly in the nebulizer market.